Reconstitution and characterization of antibody repertoires of HIV-1-infected “elite neutralizers”
Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy
Down-regulation of suppressor of cytokine signaling 3 by miR-122 enhances interferon-mediated suppression of hepatitis B virus
Carbon nanotube-based nanocarrier loaded with ribavirin against grass carp reovirus
Targeting dengue virus NS4B protein for drug discovery
Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system
Antiviral activity of theaflavin digallate against herpes simplex virus type 1
Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay
Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules
14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes
The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro
Benzouracil–coumarin–arene conjugates as inhibiting agents for chikungunya virus
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
Hepatitis C therapy with interferon-α and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV/HCV co-infected patients
The Herpes Simplex Virus-1 genome contains multiple clusters of repeated G-quadruplex: Implications for the antiviral activity of a G-quadruplex ligand
The hepatitis B virus ribonuclease H as a drug target
Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry
The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development